Abstract-The contractile response of the guinea-pig gallbladder to cholecystokinin
Several CCK antagonists have been hitherto reported (1-3), and proglumide has been the most widely used as a selective antagonist against CCK. However, the potency of proglumide as a CCK antagonist is rather low. In our previous paper (4), it was shown that benzodiazepines like CDP and DZP antagonized cholecystokinin action to contract the guinea-pig gallbladder muscle in a competitive manner, and the potency of the benzodiazepines on the antagonism was much higher than that of proglumide.
following composition (mM): NaCI, 154.0; KCI, 5.6; CaCl2, 2.2; MgCl2, 2.1, NaHCO3, 5.9; and glucose, 2.8. The muscle strips were connected via surgical silk to a force displace ment transducer for monitoring changes in isometric force. The muscle strips were equilibrated for 30 min in the Locke-Ringer solution and then applied repeatedly with agonists, 10-8 M CCK8 and 10-4 M ACh, until the contractile response to the agonists became constant. The strips were exposed to 5x10-5 M dibenamine sequentially twice for 30 min each, washed with Locke-Ringer solution for 90 min and applied with an agonist. The contractile responses of the muscle strips to an agonist before and after the exposure to dibenamine were compared. For the purpose of protecting receptors , antagonists such as atropine, benzodiazepine and proglumide were applied to the muscle strips for 15 min prior to the dibenamine treatment and during the dibenamine treatment.
CDP hydrochloride and DZP were provided from Yamanouchi Pharmaceutical Co., Ltd. (Tokyo) and proglumide from Eisai Co., Ltd. (Tokyo).
Dibenamine hydrochloride was purchased from Tokyo-Kasei Co. (Tokyo) and CCK8 from Protein Research Foundation (Osaka).
Significant differences between data were assessed by Student's t-test for paired samples.
The contractile response of the gallbladder muscle to CCK8 was significantly depressed by 60 min exposure of the muscle to 5x10-5 M of dibenamine, and the depression of the response by dibenamine was significantly prevented i n the presence of 10-4 M C D P and DZP, but not prevented by 10-6 M atropine and 10-2 M proglumide.
On the other hand, the inhibition of the contractile response of the gallbladder to ACh by dibenamine exposure was significantly prevented by 10-6 M atropine but not by 10-4 M CDP (Table 1) . significantly (P<0.05) inhibited to 56.5± 5.3% by application of 10-5 M dibenamine and more significantly (P<0.01) to 39.6± 1.7% by 10-4 M dibenamine. Therefore, we used 5x10-5 M dibenamine in the present receptor protection experiments (Table 2) . Table 1 . Effect of chlordiazepoxide and atropine on the dibenamine (5X10-5 M)-induced inhibition of the contractile response of guinea-pig gallbladder to ACh (10-4 M) Table 2 . Effect of chlordiazepoxide, diazepam, proglumide and atropine on the dibenamine (5x10-5 M)-induced inhibition of the contractile response of guinea-pig gallbladder to CCK8 (10-g M)
Dibenamine has been widely used as an irreversible alkylating agent for ACh (7, 8), histamine (8, 9) and a-adrenergic receptors (8, 10, 11). In the present work, it was demonstrated that the CCK receptor of the guinea-pig gallbladder muscle was also irreversibly inhibited by dibenamine, and the inhibition was significantly protected in the presence of 10-4 M CDP and DZP. In the previous paper, authors demonstrated that CDP and DZP caused significant rightward parallel shift of the dose-response curve for CCK when they were present in concen trations of 10-5 M to 10-6 M, and Schild analysis of the parallel shift of the CCK 
